MedPath

Y's Therapeutics, Inc.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.ysthera.com

Clinical Trials

4

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:1
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (66.7%)
Phase 1
1 (33.3%)

YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation

Phase 2
Conditions
Ischemia Reperfusion Injury
Interventions
Drug: recombinant P-selectin glycoprotein ligand Ig fusion protein
Drug: Viaspan® and saline
First Posted Date
2009-04-07
Last Posted Date
2009-04-07
Lead Sponsor
Y's Therapeutics, Inc.
Target Recruit Count
36
Registration Number
NCT00876902
Locations
🇺🇸

UCLA School of Medicine, Los Angeles, California, United States

YSPSL for Prevention of Delayed Graft Function in Cadaveric Liver Transplantation

Phase 2
Conditions
Liver Diseases
Interventions
Drug: Placebo
First Posted Date
2007-03-22
Last Posted Date
2008-01-29
Lead Sponsor
Y's Therapeutics, Inc.
Target Recruit Count
12
Registration Number
NCT00450398
Locations
🇺🇸

UCLA School of Medicine, Los Angeles, California, United States

YSPSL for Prevention of Delayed Graft Function Part A

Completed
Conditions
Delayed Graft Function
First Posted Date
2006-03-01
Last Posted Date
2008-01-29
Lead Sponsor
Y's Therapeutics, Inc.
Target Recruit Count
15
Registration Number
NCT00298181
Locations
🇺🇸

Dumont-UCLA Transplant Center, Los Angeles, California, United States

🇺🇸

California Pacific Medical Center Department of Transplantation, San Francisco, California, United States

🇺🇸

Lifelink Foundation, Tampa, Florida, United States

and more 7 locations

YSPSL for Prevention of Delayed Graft Function Part B

Phase 1
Completed
Conditions
Kidney Diseases
Interventions
Drug: placebo
First Posted Date
2006-03-01
Last Posted Date
2008-01-29
Lead Sponsor
Y's Therapeutics, Inc.
Target Recruit Count
60
Registration Number
NCT00298168
Locations
🇺🇸

Dumont-UCLA Transplant Center, Los Angeles, California, United States

🇺🇸

California Pacific Medical Center Department of Transplantation, San Francisco, California, United States

🇺🇸

University of Colorado Health Sciences Center, Denver, Colorado, United States

and more 12 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.